Drug Trial Radar · NCT07253285
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
460
Planned (sponsor's estimate)
Start
Jan 8, 2026
Primary completion
Mar 20, 2030
Study completion Sep 20, 2033
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Nov 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 8 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will look at how well CagriSema and cagrilintide help children and adolescents with excess body weight lose weight. The study has 2 parts: main and extension study. In the main study, participants will either get CagriSema (a new study drug), cagrilintide (a new study drug), semaglutide (a drug that doctors can already prescribe to adolescents and adults) or placebo (a placebo looks like the treatment being tested, but doesn't have any active ingredients in it). Which treatment participants will get is decided by chance. Participants who get semaglutide in the main study will not take part in the extension study. If participants take part in the extension study, they will get either CagriSema or cagrilintide in this part of the study. Like all drugs, the study drugs may have side effects. The total time participants will be in the main study is about 1 year and 6 months. If participants take part in the extension study, the total time is about 4 years and 10 months.
Conditions
- Overweight
- Obesity
Interventions
CagrilintideDrug
Participants will receive cagrilintide subcutaneously.
SemaglutideDrug
Participants will receive semaglutide subcutaneously.
Placebo cagrilintideDrug
Participants will receive placebo matched to cagrilintide subcutaneously.
Placebo semaglutideDrug
Participants will receive placebo matched to semaglutide subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change in body mass index (BMI)Time frame: Baseline (week 0), week 68
Locations
121 sites in 26 countries. Site status is shown where the registry gives one.
Neighborhood Healthcare
Escondido, California · Recruiting
Encore Medical Research LLC
Hollywood, Florida · Recruiting
Jacksonville Ctr for Clin Res
Jacksonville, Florida · Recruiting
Encore Medical Research of Weston
Weston, Florida · Recruiting
Children's Healthcare Atlanta
Atlanta, Georgia · Recruiting
Columbus Research Foundation
Columbus, Georgia · Recruiting
Accel Research Sites-NeuroStudies
Decatur, Georgia · Recruiting
Eastside Bariatric and Gen Surg
Snellville, Georgia · Recruiting
Solaris Clinical Research
Meridian, Idaho · Recruiting
IU Health - Riley Physicians Endo-Diab
Indianapolis, Indiana · Recruiting
Cotton O'Neil Clinical Research Center
Topeka, Kansas · Recruiting
Pennington Biomed Res Ctr
Baton Rouge, Louisiana · Recruiting
Barry J. Reiner, MD LLC
Baltimore, Maryland · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
Synexus Clinical Research US-MN
Richfield, Minnesota · Recruiting
UBMD Physicians Group - Pediatrics - Conventus
Buffalo, New York · Not yet recruiting
SUNY Upstate Medical Univ - Syracuse
Syracuse, New York · Recruiting
Advantage Clinical Trials
The Bronx, New York · Not yet recruiting
Valley Weight Loss Clinic
Fargo, North Dakota · Recruiting
Centricity Research - Ohio
Columbus, Ohio · Recruiting
PriMed Clinical Research
Dayton, Ohio · Recruiting
Children's Physicians OU
Oklahoma City, Oklahoma · Not yet recruiting
UPMC Child Hosp-Pittsburgh
Pittsburgh, Pennsylvania · Not yet recruiting
Prisma Health-Ped Endo
Greenville, South Carolina · Not yet recruiting
Coastal Carolina Research Ctr
North Charleston, South Carolina · Recruiting
Monument Health Clinical Rsrch
Rapid City, South Dakota · Not yet recruiting
LifeDoc Health
Memphis, Tennessee · Recruiting
DM Clinical
Houston, Texas · Recruiting
DM Clinical
San Antonio, Texas · Not yet recruiting
The Texas Liver Institute
San Antonio, Texas · Recruiting
Pinnacle Clinical Research
San Antonio, Texas · Recruiting
Consano Clin Res-Shavano Park
Shavano Park, Texas · Recruiting
Texas Valley Clinical Research
Weslaco, Texas · Recruiting
AMR Clinical
Layton, Utah · Recruiting
The Children's Hospital at Westmead - Clinical Research Centre
Westmead, New South Wales, Australia · Recruiting
Queensland Children's Hospital
South Brisbane, Queensland, Australia · Recruiting
Perth Children's Hospital
Nedlands, Western Australia, Australia · Recruiting
Universitätsklinik Kinder-Jugendheilkunde Innsbruck
Innsbruck, Austria · Recruiting
Universitätsklinik für Kinder und Jugendheilkunde Haus E
Salzburg, Austria · Recruiting
UZ Brussel - Universitair Ziekenhuis Brussel
Brussels, Belgium · Recruiting
Showing 40 of 121 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.